Insu Therapeutics, a portfolio company of Victory Square Technologies, received a Notice of Allowance from the US Patent Office for its buccal peptide-delivery technology. This patent supports Insu's development of InsuTab™ and BuccaGLP™, investigational formulations for insulin and semaglutide that offer a needle-free alternative by delivering peptides through the mouth lining. The technology is licensed exclusively worldwide from the University of British Columbia, and Hydreight Technologies holds exclusive US distribution rights pending regulatory approval. This milestone strengthens Insu's intellectual property foundation as it advances its programs targeting diabetes and metabolic diseases, with potential for future partnerships and commercial opportunities.
Victory Square's Insu Therapeutics patent news is presented here with Pluang's health sector market data for context. As of Oct 08, 2026 18:11 WIB, out of 100 priced US health stocks on Pluang, 25 rose and 68 fell. Among notable movers, RXRX traded at USD 4.15 with 95% sell orders and a typical hold time of 22 days, contrasting with TWST at USD 151.90 showing 97% buy orders and a 27-day hold, while HRTX at USD 0.38 had a 70% buy order share and the longest hold time of 35 days.
CIQ has released Fuzzball 4.3, a platform that enables enterprises to deploy validated open-weight AI models and agents on their existing GPU infrastructure with a single command. This update simplifies operationalizing AI by automatically connecting...
As of September 30, 2026, Societe Generale's share capital consists of 739,264,232 shares with a total of 821,169,560 voting rights. The bank highlights its strong global presence with 110,000 employees serving 27 million clients across 58 countries....
Weyerhaeuser's stock recently dropped to a new 52-week low of $18.31, trading around $18.51, reflecting market pressure. Analysts have mixed views: Seaport Global lowered its price target to $30, Raymond James upgraded to "strong buy" with the same t...
Canadian Utilities and Emera have agreed to merge as equals, creating a larger utility and energy infrastructure company. RBC Capital maintains a 'Sector Perform' rating on Canadian Utilities, indicating expected performance in line with the sector. ...
Domino's Pizza is set to report its Q3 earnings on October 13, 2026, with analysts forecasting earnings per share between $4.33 and $4.36 and revenue around $1.17 billion, a 1.6% increase year-over-year. Investors will watch closely how promotional d...
